D-1059-2014 Class III Terminated

Recalled by Greenstone Llc — Peapack, NJ

FDA drug recall D-1059-2014 was initiated by Greenstone Llc on Nov 4, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval The recall status is terminated (terminated Jun 24, 2015). Affected quantity: 22,529 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 12, 2014
Initiation Date
Nov 4, 2013
Termination Date
Jun 24, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,529 bottles

Product description

Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2

Reason for recall

Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval

Distribution pattern

US Nationwide (including PR)

Code information

lot V112000, EXP Jun 2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1059-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1059-2014. Report a data issue: hello@regdatalab.com.